期刊文献+

细胞毒T淋巴细胞相关抗原4基因多态性与吸毒并HIV感染相关

Relationship between cytotoxic T lymphocyte-associated antigen 4 gene haplotype and drug use accompanied with HIV infection
下载PDF
导出
摘要 目的研究细胞毒T淋巴细胞相关抗原4(CTLA-4)基因外显子1的49位点A/G和启动子-318位点C/T多态性与吸毒并HIV感染的相关性。方法 采用序列特异性引物聚合酶链反应(PCR-SSP)方法,检测24例单纯吸毒者、41例吸毒合并HIV感染患者以及204例正常对照者CTLA-4基因外显子1的49位点A/G和启动子-318位点C/T的基因型。结果 与正常对照组比较,吸毒组C/C(12.50%vs51.47%)(P<0.01)型频率明显下降;在吸毒合并HIV感染患者组,CTLA-4A+49G基因型差异无统计学意义(P>0.05);CTLA-4C-318T基因型差异有统计学意义(P<0.01),C/T(68.3%vs45.6%)、T/T(21.95%vs2.94%)型频率明显上升,C/C(9.76%vs51.47%)型频率显著下降。与吸毒组比较,吸毒合并HIV感染组中CTLA-4A+49G及CTLA-4C-318T各基因型频率变化无统计学差异(P>0.05)。结论 吸毒合并HIV感染与CTLA-4基因动态密切相关,C-318T基因型C/T、T/T型与吸毒合并HIV感染呈正相关,C/C行呈负相关。 Objective To investigate the association of gene polymorphism of cytotoxic T lymphocyte-associated antigen 4(CTLA-4) with drug users with HIV infection.Methods The A+49G transition polymorphism at position 49(exon 1) and C-318T transition polymorphism at position 318 in promoter of the CTLA-4 gene were determined by polymerase chain reaction with sequence specific primers(PCR-SSP) method in 24 drug users,41 drug users with HIV Infection patients and 204 healthy controls.Results Compared with control group,in drug users group the frequency of C/C(12.50% vs 51.47%)(P0.01) significantly reduced;in drug users with HIV infection group,no significant differences in the distribution of genotype and allele frequencies were observed in A+49G gene polymorphisms(P0.05);however,there were significant differences in C-318T gene polymorphisms in drug users with HIV infection group(P0.01),the frequency of C/T(68.3% vs 45.6%) and T/T(21.95% vs2.94%)increased significantly,in contrast in C/C(9.76% vs 51.47%)significantly reduced.Compared with drug users group,no significant differences in the distribution of genotype and allele frequencies were observed in A+49G and C-318T gene polymorphisms(P0.05) in drug users with HIV infection group.Conclusion There is a close relation between CTLA-4 Alleles and drug use with HIV infection,in C-318T genotype,C/T and T/T are positively correlated with occurence of drug use with HIV infection,but C/C is negatively correlated with it.
出处 《基础医学与临床》 CSCD 北大核心 2011年第7期736-739,共4页 Basic and Clinical Medicine
基金 国家自然科学基金(30972754) 中央高校基本科研业务费专项资金资助
关键词 吸毒并HIV感染 细胞毒T淋巴细胞相关抗原4 基因多态性 基因型 drug users with HIV infection cytotoxic T lymphocyte-associated antigen gene polymorphism genotype
  • 相关文献

参考文献10

  • 1Yao Q, Fischer KP, Motyka B, et al. Identification of cyto- toxic T-lymphocyte-associated antigen4 (CTLA4) isoforms in the Pekin duck [ J ]. Dev Comp Immunol, 2010,34:749 - 758.
  • 2Teft WA, Madrenas J. Characterization of oligomers induced by inverse agonists of CTLA-4 [ J ]. Immunol Lett, 2008, 120 : 29 - 36.
  • 3Ben-Shoshan M. CTLA-4Ig: uses and future directions[ J]. Recent Pat Inflamm Allergy Drug Discov, 2009, 3:132 - 142.
  • 4Jain N, Nguyen H, Chambers C, et al. Dual function of CTLA-4 in regulatory T cells and conventional T cells to prevent muhiorgan autoimmunity [ J ]. Proc Natl Acad Sci USA, 2010,107:1524 - 1528.
  • 5McNicholl JM, Promadej N. Insights into the role of host genetic and T-cell factors in resistance to HIV transmission from studies of highly HIV-exposed Thais [ J ]. Immunol Res, 2004, 29 : 161 - 174.
  • 6Ligers A, Teleshova N, Masterman T, et al. CTLA-4 gene expression is influenced by promoter and exon 1 polymor- phisms[J]. Genes Immun, 2001, 2:145 - 152.
  • 7Stohl W, Xu D, Kim KS, et al. MHC class Ⅱ-independent and-dependent T cell expansion and B cell hyperactivity in vivo in mice deficient in CD152 (CTLA-4)[ J]. Int Immu- nol,2004,16:895 - 904.
  • 8Lira A, French MA, Price P. CD4^+ and CD8^+ T cells ex- pressing FoxP3 in HIV-infected patients are phenotypically distinct and influenced by disease severity and antiretroviral therapy [ J ]. J Acquir Immune Defic Syndr, 2009,51 : 248 - 257.
  • 9Kaufmann DE, Kavanagh DG, Pereyra F, et al. Upregula- tion of CTLA-4 by HIV-specific CD4 ^+ T cells correlates with disease progression and defines a reversible immune dysfunction [ J ]. Nat Immunol,2007,8 : 1246 - 1254.
  • 10Deichmann K, Heinzmann A, Bruggenolte E, et al. AnMse Ⅰ RFLP in the human CTLA-4 promoter [ J ]. Biochem Biophys Res Commun, 1996, 225 : 817 - 818.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部